Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis.

E W Rauterberg, H M Lieberknecht, A M Wingen

    Kidney International
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Angiotensin-II-receptor inhibitors in pregnancy.

    Lancet (London, England)·2001
    Same author

    Impact of ACE I/D gene polymorphism on congenital renal malformations.

    Pediatric nephrology (Berlin, Germany)·2001
    Same author

    Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.

    The Pediatric infectious disease journal·2001
    Same author

    Platelet adenylyl cyclase signaling remains unaltered in children undergoing hemodialysis treatment.

    Pediatric nephrology (Berlin, Germany)·2001
    Same author

    Hypothyroidism mimicking chronic renal failure in reflux nephropathy.

    Archives of disease in childhood·2000
    Same author

    Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

    Pediatric nephrology (Berlin, Germany)·2000
    Same journal

    Why current evidence does not support routine C5 inhibition in STEC-HUS.

    Kidney international·2026
    Same journal

    Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.

    Kidney international·2026
    Same journal

    KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

    Kidney international·2026
    Same journal

    KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

    Kidney international·2026
    Same journal

    Crystal-storing histiocytosis causing severe acute kidney injury.

    Kidney international·2026
    Same journal

    Peritoneal dialysis in a patient with extensive burn scarring.

    Kidney international·2026
    See all related articles

    The membrane attack complex (MAC) of complement is present in IgA-glomerulonephritis (IgA-GN) and Henoch-Schönlein purpura nephritis (HSP). This suggests MAC may play a role in the pathogenesis of these kidney diseases.

    Area of Science:

    • Immunology
    • Nephrology
    • Pathology

    Background:

    • IgA-glomerulonephritis (IgA-GN) and Henoch-Schönlein purpura nephritis (HSP) are kidney diseases characterized by immunoglobulin A deposits.
    • The role of the complement system, particularly the membrane attack complex (MAC), in the pathogenesis of these conditions is not fully understood.

    Purpose of the Study:

    • To investigate the presence and distribution of MAC antigens in kidney biopsies from patients with IgA-GN and HSP.
    • To correlate MAC deposition with immunoglobulin and complement deposition patterns.
    • To explore the potential role of MAC in the pathogenesis of IgA-GN and HSP.

    Main Methods:

    • Immunohistochemical staining for MAC antigens (C5, C6, C9, neoantigens), classical pathway markers (Clq, C4), and complement fragments (C3b/iC3b, C3d).

    Related Experiment Videos

  • Dot-blot analysis to verify antibody specificity.
  • Correlation analysis of glomerular deposition patterns for IgA, IgG, IgM, and complement components.
  • Double immunostaining to assess co-localization of IgA and MAC neoantigens.

    • Main Results:

    • MAC antigens were detected in the mesangium of most IgA-GN and HSP cases.
    • Classical pathway activation markers were rarely observed, suggesting alternative pathway involvement.
    • IgA and MAC neoantigen deposition showed significant co-localization in glomeruli.
    • MAC deposition patterns correlated with IgA and C3b/iC3b distribution.
    • MAC staining intensity was lower in minimal lesion cases compared to advanced lesions.

    Conclusions:

    • The findings indicate local complement activation via the alternative pathway in IgA-GN and HSP, leading to MAC formation.
    • MAC deposition in glomeruli suggests a potential pathogenetic role in these kidney diseases.
    • Further research is warranted to elucidate the specific mechanisms by which MAC contributes to kidney damage.